Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA approves new intravenous formulation of Triferic

March 30, 2020

Otsuka Pharmaceutical identifies AhR antagonists

March 25, 2020

Desmopressin shows promise for the management of bleeding in rectal cancer

March 20, 2020

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

March 19, 2020

Novo Nordisk announces decision to pause concizumab trials in hemophilia

March 17, 2020

Keeping stem cells quiescent enables greater ultimate potency

March 10, 2020

BioCryst initiates proof-of-concept trial of BCX-9930 in PNH

March 6, 2020

Omeros reports new data from pivotal trial of narsoplimab for HSCT-TMA

March 3, 2020

Phase I data for novel lentiviral vector therapy for children with Fanconi anemia

Feb. 28, 2020

Bluebird bio presents phase I/II data on LentiGlobin for sickle cell disease

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026